PlainRecalls

Cbi Laboratories, Inc.

Compiled from official public sources by the publisher.

2 recalls on record · Latest: Dec 26, 2018

Subscribe to new Cbi Laboratories, Inc. recalls (RSS)

Agency notice ledger

Federal filing book Cbi Laboratories, Inc. LIGHT-BOOK · SINGLE-AGENCY

#4,553 of 14,151 · 2 notices · 0.002% archive

  • BOOK 2 notices
  • RANK #4,553 of 14,151
  • SHARE 0.002% archive
  • AGENCY FDA Drug (2)
  • CAT drugs
  • CATS 1 category
  • LATEST Dec 26, 2018
  • PHOTO 3M Company

Nearest notice-volume peer: 3M Company (0 notice gap)

Cbi Laboratories, Inc. accounts for about 0.002% of the 104,423-notice archive on 2 distinct filings — a light share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

How Cbi Laboratories, Inc. compares to 14,151 recalling firms

Cbi Laboratories, Inc. ranks 4,553rd of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Cbi Laboratories, Inc. vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

2 4553rd of 14151 higher than 8,037 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

Cbi Laboratories, Inc. in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Cbi Laboratories, Inc. holds about 0.002% of archive notices alongside 2 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Low Dec 26, 2018

Advanced Protection Sunscreen spf 30 (Octinoxate 7.5%, Octisalate 5%, Oxybenzone 6%), 4.5 Oz/127.5 g tube.
FDA Drug Low Dec 26, 2018

Options Rx Anti-Oxidant Oil-Free Sunscreeen (Octinoxate 7.5%, Octisalate 5%, Oxybenzone 6%), 4.5 oz./128 g tube, Mfg. For Credentials Skincare Fort Worth, TX 76155

Cbi Laboratories, Inc. is a small archive contributor

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Frequently Asked Questions

How many federal recall notices name Cbi Laboratories, Inc.? ▼
PlainRecalls indexes 2 distinct federal recall events naming Cbi Laboratories, Inc., aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Cbi Laboratories, Inc. sit among other recalling firms? ▼
Cbi Laboratories, Inc. ranks #4,553 of 14,151 by distinct recall-event count among 14,151 firms in this archive (57th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Cbi Laboratories, Inc.'s notices? ▼
FDA Drug accounts for 2 of this firm's 2 indexed notices.
What product category dominates Cbi Laboratories, Inc.'s filing book? ▼
Filings for Cbi Laboratories, Inc. span 1 product category, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Cbi Laboratories, Inc.: 2 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Cbi Laboratories, Inc.; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026